182 related articles for article (PubMed ID: 37759302)
1. Suppression of the antitumoral activity of natural killer cells under indirect coculture with cancer-associated fibroblasts in a pancreatic TIME-on-chip model.
Kim HA; Kim H; Nam MK; Park JK; Lee MY; Chung S; Lee KM; Kuh HJ
Cancer Cell Int; 2023 Sep; 23(1):219. PubMed ID: 37759302
[TBL] [Abstract][Full Text] [Related]
2. Multiplex quantitative analysis of stroma-mediated cancer cell invasion, matrix remodeling, and drug response in a 3D co-culture model of pancreatic tumor spheroids and stellate cells.
Hwang HJ; Oh MS; Lee DW; Kuh HJ
J Exp Clin Cancer Res; 2019 Jun; 38(1):258. PubMed ID: 31200779
[TBL] [Abstract][Full Text] [Related]
3. Anti-Cancer Activity Profiling of Chemotherapeutic Agents in 3D Co-Cultures of Pancreatic Tumor Spheroids with Cancer-Associated Fibroblasts and Macrophages.
Jang SD; Song J; Kim HA; Im CN; Khawar IA; Park JK; Kuh HJ
Cancers (Basel); 2021 Nov; 13(23):. PubMed ID: 34885065
[TBL] [Abstract][Full Text] [Related]
4. Microfluidic co-culture of pancreatic tumor spheroids with stellate cells as a novel 3D model for investigation of stroma-mediated cell motility and drug resistance.
Lee JH; Kim SK; Khawar IA; Jeong SY; Chung S; Kuh HJ
J Exp Clin Cancer Res; 2018 Jan; 37(1):4. PubMed ID: 29329547
[TBL] [Abstract][Full Text] [Related]
5. Co-Culture of Tumor Spheroids and Fibroblasts in a Collagen Matrix-Incorporated Microfluidic Chip Mimics Reciprocal Activation in Solid Tumor Microenvironment.
Jeong SY; Lee JH; Shin Y; Chung S; Kuh HJ
PLoS One; 2016; 11(7):e0159013. PubMed ID: 27391808
[TBL] [Abstract][Full Text] [Related]
6. Cellular context-dependent interaction between cancer and stellate cells in hetero-type multicellular spheroids of pancreatic tumor.
Nam S; Khawar IA; Park JK; Chang S; Kuh HJ
Biochem Biophys Res Commun; 2019 Jul; 515(1):183-189. PubMed ID: 31133378
[TBL] [Abstract][Full Text] [Related]
7. Phenotypic Heterogeneity and Plasticity of Cancer Cell Migration in a Pancreatic Tumor Three-Dimensional Culture Model.
Kim SK; Jang SD; Kim H; Chung S; Park JK; Kuh HJ
Cancers (Basel); 2020 May; 12(5):. PubMed ID: 32455681
[TBL] [Abstract][Full Text] [Related]
8. Different effects of NK cells and NK-derived soluble factors on cell lines derived from primary or metastatic pancreatic cancers.
Fiore PF; Di Pace AL; Conti LA; Tumino N; Besi F; Scaglione S; Munari E; Moretta L; Vacca P
Cancer Immunol Immunother; 2023 Jun; 72(6):1417-1428. PubMed ID: 36451048
[TBL] [Abstract][Full Text] [Related]
9. Understanding and Targeting Natural Killer Cell-Cancer-Associated Fibroblast Interactions in Pancreatic Ductal Adenocarcinoma.
Malchiodi ZX; Weiner LM
Cancers (Basel); 2021 Jan; 13(3):. PubMed ID: 33499238
[TBL] [Abstract][Full Text] [Related]
10. DPP inhibition alters the CXCR3 axis and enhances NK and CD8+ T cell infiltration to improve anti-PD1 efficacy in murine models of pancreatic ductal adenocarcinoma.
Fitzgerald AA; Wang S; Agarwal V; Marcisak EF; Zuo A; Jablonski SA; Loth M; Fertig EJ; MacDougall J; Zhukovsky E; Trivedi S; Bhatia D; O'Neill V; Weiner LM
J Immunother Cancer; 2021 Nov; 9(11):. PubMed ID: 34737215
[TBL] [Abstract][Full Text] [Related]
11. Engineered Three-Dimensional Tumor Models to Study Natural Killer Cell Suppression.
Temples MN; Adjei IM; Nimocks PM; Djeu J; Sharma B
ACS Biomater Sci Eng; 2020 Jul; 6(7):4179-4199. PubMed ID: 33463353
[TBL] [Abstract][Full Text] [Related]
12. Pseudopterosin and
Xie B; Hänsel J; Mundorf V; Betz J; Reimche I; Erkan M; Büdeyri I; Gesell A; Kerr RG; Ariantari NP; Yu H; Proksch P; Teusch N; Mrsny RJ
Bioengineering (Basel); 2020 Jun; 7(2):. PubMed ID: 32545910
[TBL] [Abstract][Full Text] [Related]
13. Cocultures of human colorectal tumor spheroids with immune cells reveal the therapeutic potential of MICA/B and NKG2A targeting for cancer treatment.
Courau T; Bonnereau J; Chicoteau J; Bottois H; Remark R; Assante Miranda L; Toubert A; Blery M; Aparicio T; Allez M; Le Bourhis L
J Immunother Cancer; 2019 Mar; 7(1):74. PubMed ID: 30871626
[TBL] [Abstract][Full Text] [Related]
14. Enhancement of NK cell antitumor responses using an oncolytic parvovirus.
Bhat R; Dempe S; Dinsart C; Rommelaere J
Int J Cancer; 2011 Feb; 128(4):908-19. PubMed ID: 20473905
[TBL] [Abstract][Full Text] [Related]
15. Synergistic therapeutic combination with a CAF inhibitor enhances CAR-NK-mediated cytotoxicity via reduction of CAF-released IL-6.
Lee YE; Go GY; Koh EY; Yoon HN; Seo M; Hong SM; Jeong JH; Kim JC; Cho D; Kim TS; Kim SC; Jun E; Jang M
J Immunother Cancer; 2023 Feb; 11(2):. PubMed ID: 36849201
[TBL] [Abstract][Full Text] [Related]
16. Elevation of MMP-9 and IDO induced by pancreatic cancer cells mediates natural killer cell dysfunction.
Peng YP; Zhang JJ; Liang WB; Tu M; Lu ZP; Wei JS; Jiang KR; Gao WT; Wu JL; Xu ZK; Miao Y; Zhu Y
BMC Cancer; 2014 Oct; 14():738. PubMed ID: 25274283
[TBL] [Abstract][Full Text] [Related]
17. Ultrasound-induced Cavitation enhances the efficacy of Chemotherapy in a 3D Model of Pancreatic Ductal Adenocarcinoma with its microenvironment.
Leenhardt R; Camus M; Mestas JL; Jeljeli M; Abou Ali E; Chouzenoux S; Bordacahar B; Nicco C; Batteux F; Lafon C; Prat F
Sci Rep; 2019 Dec; 9(1):18916. PubMed ID: 31831785
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-15 stimulates natural killer cell-mediated killing of both human pancreatic cancer and stellate cells.
Van Audenaerde JRM; De Waele J; Marcq E; Van Loenhout J; Lion E; Van den Bergh JMJ; Jesenofsky R; Masamune A; Roeyen G; Pauwels P; Lardon F; Peeters M; Smits ELJ
Oncotarget; 2017 Aug; 8(34):56968-56979. PubMed ID: 28915646
[TBL] [Abstract][Full Text] [Related]
19. Pancreatic stellate cells regulate branched-chain amino acid metabolism in pancreatic cancer.
Jiang W; Qiao L; Han Y; Zhang A; An H; Xiao J; Ren L
Ann Transl Med; 2021 Mar; 9(5):417. PubMed ID: 33842638
[TBL] [Abstract][Full Text] [Related]
20. Cancer-associated fibroblast suppresses killing activity of natural killer cells through downregulation of poliovirus receptor (PVR/CD155), a ligand of activating NK receptor.
Inoue T; Adachi K; Kawana K; Taguchi A; Nagamatsu T; Fujimoto A; Tomio K; Yamashita A; Eguchi S; Nishida H; Nakamura H; Sato M; Yoshida M; Arimoto T; Wada-Hiraike O; Oda K; Osuga Y; Fujii T
Int J Oncol; 2016 Oct; 49(4):1297-304. PubMed ID: 27499237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
